STC1 and cervical cancer: The results of IOD analysis revealed that the level of STC1 in cervical cancer was significantly associated with tumor stage (p=0.034, Figure 1B), but did not differ depending on patient age (<45 years or ≥45 years, p=0.237; Supplementary Table 1), implying that STC1 might act as a potential cancer biomarker.